Briggs Morrison, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 70,312 shares at $20.55 ($1.4M) on 2021-02-08, disclosed to the SEC on 2021-02-10.
Open-market sale of $1.4M SNDX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.55 | 35,156 | $722K | 50.0% |
| 2 | $20.55 | 35,156 | $722K | 50.0% |
| Total | $20.55 avg | 70,312 | $1.4M | 100% |
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-07-11 | $1.1M | — | Filing → |
| SNDX | SELL | 2023-06-09 | $2.2M | — | Filing → |